The Financial Times notes that German drug marker Schering is embarking on a big stem cell research and development venture in Japan. Legislative and cultural conditions in Asia are far more condusive to this sort of aging research. Japan even has a "Respect the Aged" holiday! From the article: "When compared to the situation in the US and especially when compared to Germany, the conditions for cell research in Japan appear to be the most modern. The Japanese government has fully recognised the needs and the challenges of an ageing society."